Application of risk stratification scores in acute myocardial infarction;Application des scores de stratification du risque dans l'infarctus du myocarde en phase: Aiguë: Données de RICO (observatoire des infarctus de Côte-d'Or)

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 9, 2003, Pages 841-847

  Zeller, M ^a   Ravisy, J ^b   L'Huillier, I ^a   Touzery, C ^a   Laurent, Y ^c   Janin Manificat, L ^c   Makki, H ^c   Jolak, M ^c   Dentan, G ^b   Beer, J C ^a   Cottin, Y ^a   Wolf, J E ^a  

^a HÔPITAL DU BOCAGE   (France)

^b Clinique de Fontaine   (France)

^c CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FRANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS;

AGED; COTE D'IVOIRE; ELECTROENCEPHALOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGRESSION ANALYSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 0141680535     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Danchin N. Stratéqies thérapeutiques au stade aigu de l'infarctus du myocarde. Arch Mal Cœur 1998; 91: 7-8.
2. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombalytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-5.
3. Loubeyre C, Lefevre T, Louvard Y et al. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 2001; 22: 1067-9.
4. Bonnefoy E, Lapostolle F, Leizorovicz A et al. Comparison of angioplasty and pre-hospital thrombolysis in acute myocardial infarction study group. Lancet 2002; 360: 814-6.
5. Morrow DA, Antamnn M, Charlesworth A et al. TIMI risk score for ST-elevation myocardia infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation 2000; 102: 2031-7.
6. Califf RM, Pieper KS, Lee KL et al. for the GUSTO I investigators. Prediction of 1-Year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and tPA for occluded coronary arteries trial. Circulation 2000; 101: 2231-8.
7. Antmann EM, Cohen M, Berninck PJ et al. The TIMI risk score for unstable angina/non-ST Elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-42.
8. Boersma E, Pieper KS, Sqteyberg EW et al. for the PURSUIT investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-elevatian. Results from an international trial of 9461 patients. Circulation 2000; 101: 2557-67.
9. Myocardial infarction redefined a consensus document of The Joint European Society of Cardiology/American Colleqe of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000; 36: 959-69.
10. Singh M, Reeder GS, Jacobsen SJ, Weston S, Killian J, Roger VL. Scares for post-myocardial infarctian risk stratification in the community. Circulation 2002; 106: 2309-14.
11. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Sendon J. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction findings from the global Registry of Acute Coronary (GRACE). Lancet 2002; 359: 373-7.
12. Morrow DA, Antman EM, Parsons L et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA 2001; 286: 1356-9.
13. Budaj A, Yusuf S, Mehta SR et al. Benefit of clapidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002; 106: 1622-6.
14. Gumina RJ, Wright RS, Kopecky SL et al. Strong predictive value of TIMI risk scare analysis for in-hospital and long-term survival of patients with right ventricular infarction. Eur Heart J 2002; 23: 1678-83.
15. Samaha FF, Kimmel SE, Kizer JR, Goyal A, Wade M, Boden WE. Usefulness of the TIMI risk score in predicting both short - and long-term outcomes in the Veterans Affairs Non-Q-Wave Myocardial Infarction Strategies In-Hospital (VANQWISH) Trial. Am J Cardiol 2002; 90: 922-6.
16. Morrow DA, Antman EM, Snapinn SM, McCabe CH, Theroux P, Braunwald E. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002; 23: 187-91.